Janssen-Cilag

GPTKB entity

Statements (44)
Predicate Object
gptkbp:instance_of gptkb:pharmaceuticals
gptkbp:academic_programs Ms. Susan M. Mc Carthy
gptkbp:acquisition gptkb:Actelion
gptkb:Kymab
gptkb:Cure_Vac
gptkb:Tibotec_Pharmaceuticals
gptkb:Momenta_Pharmaceuticals
Aragon Pharmaceuticals
gptkbp:advertising gptkb:Dr._Jennifer_Taubert
gptkb:Mr._Michael_D._Duffy
Mr. Robert A. Mc Carthy
gptkbp:awards various industry awards
gptkbp:clinical_trial multiple ongoing studies
gptkbp:conducts_research_on gptkb:Dr._Mathai_Mammen
gptkbp:founded gptkb:1959
gptkbp:founder gptkb:Paul_Janssen
gptkbp:global_presence over 150 countries
gptkbp:head_of_state Dr. William Hait
Mr. John A. Mc Carthy
Ms. Linda M. Mc Carthy
gptkbp:headquarters gptkb:Beerse,_Belgium
https://www.w3.org/2000/01/rdf-schema#label Janssen-Cilag
gptkbp:industry gptkb:pharmaceuticals
gptkbp:number_of_employees over 30,000
gptkbp:parent_company gptkb:Johnson_&_Johnson
gptkbp:part_of Johnson & Johnson Pharmaceutical Research & Development
gptkbp:partnerships government agencies
non-profit organizations
various academic institutions
gptkbp:products antibiotics
antipsychotics
oncology drugs
gptkbp:regulatory_compliance gptkb:Ms._Jennifer_L._Mc_Carthy
gptkbp:research_focus oncology
neuroscience
infectious diseases
immunology
gptkbp:supply_chain Mr. David A. Mc Carthy
gptkbp:sustainability_initiatives community health programs
diversity and inclusion efforts
environmental responsibility programs
gptkbp:website www.janssen.com
gptkbp:bfsParent gptkb:Janssen_Pharmaceutica
gptkbp:bfsLayer 5